REG - JPMorgan EM G&I Plc - Closed Period Announcement

RNS Number : 5150N JPMorgan Emerg Mkts Growth & Income 02 January 2026 LONDON STOCK EXCHANGE ANNOUNCEMENTJPMORGAN EMERGING MARKETS GROWTH & INCOME PLC(the 'Company')Closed Period NotificationLegal Entity Identifier: 5493001VPQDYH1SSSR77Information disclosed in accordance with Market Abuse Regulation ('MAR') Article 19, paragraph 11The Company announces that it is satisfied that any inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the half year ended 31st December 2025 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore the Company is not prohibited from dealing in its own securities.The mandatory closed period under MAR will commence on 19th January 2026 and will expire when the results in respect of the half year ended 31st December 2025 are published, which is expected to be on or around 26th February 2026. If in the period leading up to the announcement of the half year results the Directors of the Company come into the possession of any inside information, this will be notified to the London Stock Exchange without delay and before any such transactions are undertaken.2nd January 2026For further information, please contact:Divya AminFor and on behalf ofJPMorgan Funds Limited - Company Secretary0800 20 40 20 (or +44 1268 44 44 70) This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCLLLFBQFLLBBE